San Diego-based Allele Biotechnology and Pharmaceuticals, Inc., officially announced a joint research and development agreement with South Korea’s SCM Lifescience Co., Ltd., for the development of diabetes therapies using pancreatic beta cells derived from induced […]
Catalent has agreed to acquire contract development and manufacturing organization (CDMO), Paragon Bioservices, in a deal valued at around $1.2bn. Paragon Bioservices is a major viral vector development and manufacturing partner for gene therapies. Paragon […]
DNAnexus and Sutter Health have partnered with the University of Pittsburgh Medical Center (UPMC) to launch a clinico-genomic study aimed at improving personalised therapy for multiple sclerosis (MS) patients. Under the large-scale research project, the […]
SMi Group are pleased to announce the next Biosimilars Conference, the first global event taking place at the Copthorne Tara Hotel in London, on 25th and 26th September 2019. The biosimilars market is forecasted to […]
The highly anticipated Pharmaceutical Microbiology West Coast Conference is returning to San Diego, USA, this June. SMi Group are pleased to have Ziva Abraham, CEO, Microrite, Inc.as the chair for the two-day conference. Ziva Abraham […]